Brazil trials of Sinovac COVID-19 vaccine show promising results: governor

SAO PAULO (Reuters) – The governor of Brazil’s São Paulo state said on Wednesday that Phase 3 clinical trials of a potential COVID-19 vaccine developed by China’s Sinovac Biotech Ltd have shown promising results and it may be available to Brazilians as early as December.

Governor João Doria added that Phase 2 trials of the potential vaccine had shown an immune response of 98% in the elderly.


By Eduardo Simões via Reuters


Read full article here


Share This

Chamber Updates Stay connected with Chamber activities